Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
23.02 USD | -4.60% | -0.52% | +126.10% |
May. 15 | Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Cullinan Therapeutics, Inc. Announces Board Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.10% | 1.39B | |
+53.89% | 63.85B | |
-1.87% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.36% | 26.52B | |
-21.43% | 18.69B | |
+2.67% | 12.73B | |
+22.31% | 12.11B | |
+27.48% | 12.07B |
- Stock Market
- Equities
- CGEM Stock
- News Cullinan Therapeutics, Inc.
- Cullinan Oncology Secures FDA Approval for CLN-619's Investigational New Drug Application in Multiple Myeloma